Together with local partners, Novartis aims to initiate a watershed development project near its own and supply chain operations in the Telangana region.

Novartis and BeiGene, Ltd. have mutually agreed to terminate the collaboration and license agreement for tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody.